Form 4: Elanco CFO Robert VanHimbergen Acquires Deferred Stock

Elanco Animal Health CFO Robert M. VanHimbergen acquired 8.3201 deferred stock units as part of a company compensation plan.

Summary

• Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health, acquired 8.3201 deferred stock units on April 17, 2026.
• The transaction was executed at a price of $23.68 per unit.
• Following this transaction, the reporting person holds a total of 65.7467 deferred stock units.
• These units represent the right to receive common stock or cash equivalent upon termination of employment or a specified future date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing related to standard executive compensation.

Positives

• The acquisition reflects continued alignment between executive compensation and company equity performance.

Negatives

• None identified.

Risks

• The value of the deferred stock units is subject to the market performance of Elanco Animal Health common stock.

Future Outlook

The deferred stock units are subject to the terms of the Executive Deferral and Stock Match Plan, settling in cash or shares upon employment termination or a specified future date.

Management Comments

• The filing notes that each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

Industry Context

StockSavvy.ai notes that routine acquisitions of deferred stock units by executives are standard components of executive compensation packages and generally do not signal a change in strategic direction or material non-public information.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation practices in the pharmaceutical and animal health sectors.
• The use of deferred stock units is a common mechanism for long-term incentive alignment used by peers such as Zoetis and Merck Animal Health.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine compensation-related transaction.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Elanco, ELAN, Insider Trading, Form 4, CFO, Deferred Stock Units